Studying Cell Growth in Cancer with Bromodeoxyuridine
Author Information
Author(s): A. Riccardi, M. Danova, P. Dionigi, P. Gaetani, T. Cebrelli, G. Butti, G. Mazzini, G. Wilson
Primary Institution: Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo
Hypothesis
Can in vivo bromodeoxyuridine infusion provide reliable kinetic data for various types of malignant tumors?
Conclusion
The study shows that in vivo bromodeoxyuridine infusion combined with flow cytometry can effectively measure cell kinetics in cancer patients.
Supporting Evidence
- Successful labelling index and DNA synthesis time determinations were obtained in 80% and 72% of patients, respectively.
- Proliferative activity was greater in responsive acute leukaemia patients compared to non-responsive ones.
- Advanced gastric cancer patients showed higher proliferative activity than those with limited disease.
- No correlations were found between kinetic parameters and clinical outcomes in gliomas.
Takeaway
Doctors can use a special method to see how fast cancer cells grow, which helps them understand the cancer better and plan treatments.
Methodology
Patients received in vivo bromodeoxyuridine infusion, and tumor samples were analyzed using flow cytometry to measure cell kinetics.
Limitations
The study faced challenges in obtaining sufficient viable cells for analysis and had a limited follow-up period.
Participant Demographics
Patients included 50 with acute leukaemia, 42 with gastric cancer, and 20 with brain gliomas, with a median age range of 16-78 years.
Statistical Information
P-Value
<0.05
Want to read the original?
Access the complete publication on the publisher's website